SHPH Earnings

Quarterly EPS
$-398.30
Q3 2024
$-43.32
Q4 2024
$-76.00
Q1 2025
$-32.91
Q2 2025
$-10.50
Q3 2025
$-6.87
Q4 2025
$-4.30
Q1 2026
$-3.10
Q2 2026
Latest RevenueN/A
Latest Net Income-3145539
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$3.100-3145539—+90.6%
Q1 2026-$4.300-2152471—+94.3%
Q4 2025-$6.870-2614895—+84.1%
Q3 2025-$10.500-2347302—+97.4%
Q2 2025-$32.910-3706465—+86.4%
Q1 2025-$76.000-3053007—+63.4%
Q4 2024-$43.320-1598469—+78.8%
Q3 2024-$398.300-3784082—-75.1%
Q2 2024-$241.200-2031215——
Q1 2024-$207.500-1731031——
Q4 2023-$203.990-1640500——
Q3 2023-$227.500-1792754——
Shuttle Pharmaceuticals (SHPH) — Earnings